Fagan Associates’s MetLife MET Stock Holding History

Fagan Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,478	Closed	-$1.12M	–	126
2022 Q4	$1.12M	Buy	15,478 +370	+2%	+$26.5K	0.3%	66
2022 Q3	$918K	Sell	15,108 -630	-4%	-$40.2K	0.26%	65
2022 Q2	$988K	Hold	15,738	–	–	0.26%	64
2022 Q1	$1.11M	Buy	15,738 +1,185	+8%	+$80.1K	0.23%	72
2021 Q4	$909K	Buy	14,553 +1,248	+9%	+$78.3K	0.17%	79
2021 Q3	$821K	Sell	13,305 -473	-3%	-$28.5K	0.18%	80
2021 Q2	$825K	Buy	13,778 +1,473	+12%	+$93.4K	0.18%	80
2021 Q1	$748K	Buy	+12,305	New	+$679K	0.17%	81
2017 Q4	–	Sell	-38,107	Closed	-$1.98M	–	109
2017 Q3	$1.98M	Sell	38,107 -4,151	-10%	-$202K	0.98%	34
2017 Q2	$2.07M	Buy	42,258 +2,997	+8%	+$139K	1.08%	34
2017 Q1	$1.85M	Buy	39,261 +1,874	+5%	+$89.3K	1.02%	31
2016 Q4	$1.8M	Buy	+37,387	New	+$1.71M	1.04%	34

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fagan Associates's MET Position: Q1 2023 in Review

Fagan Associates sold out of MetLife (MET) in Q1 2023, closing a stake of 15,478 shares — an estimated $1.12M sold.

Fagan Associates first reported a position in MET in Q4 2016 and held it in 12 quarters. The position peaked at $2.07M in Q2 2017. 1,213 funds tracked by Wall St. Rank hold MET as of Q1 2023.

Fagan Associates reported no remaining MetLife position as of Q1 2023 after selling out during the quarter.
Fagan Associates sold 15,478 MetLife shares in Q1 2023, an estimated $1.12M.
Fagan Associates first reported a position in MetLife in Q4 2016 and held it in 12 quarters.
Fagan Associates's MetLife position peaked at $2.07M in Q2 2017.
1,213 funds tracked by Wall St. Rank held MetLife as of Q1 2023.

Based on Fagan Associates's 13F filing for Q1 2023, filed 4 May 2023.